CanStem303C
A Phase III Study of BBI- 608 in Combination With [...]
A Phase III Study of BBI- 608 in Combination With [...]
A Phase III Study of BBI- 608 Plus Nab- Paclitaxel [...]
A Phase 3, Double-blind, Randomized Study to Compare the Efficacy [...]
RECOVER: Phase 2 Randomized, Double-Blind Trial Treating Hospitalized Patients with [...]
A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib [...]
A Phase III, Randomized, Controlled, Double-Blind Study Evaluating the Safety [...]
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Resistant [...]
Combination of MEK Inhibitor Binimetinib and CDK4/6 Inhibitor Palbociclib in [...]
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated [...]
Principal Investigator Jian L. Campian, MD, PhD, is a medical [...]